maropitant has been researched along with voriconazole in 1 studies
| Studies (maropitant) | Trials (maropitant) | Recent Studies (post-2010) (maropitant) | Studies (voriconazole) | Trials (voriconazole) | Recent Studies (post-2010) (voriconazole) |
|---|---|---|---|---|---|
| 74 | 36 | 56 | 4,390 | 219 | 2,678 |
| Protein | Taxonomy | maropitant (IC50) | voriconazole (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 8.4 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 8.7 | |
| Cholesterol 24-hydroxylase | Homo sapiens (human) | 0.0345 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sebestyén, Z; Szabó, B; Szepesi, K | 1 |
1 review(s) available for maropitant and voriconazole
| Article | Year |
|---|---|
[Pharmaceutical applications of sulfobuthylether-beta-cyclodextrin].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antiemetics; Antifungal Agents; Antipsychotic Agents; Aripiprazole; beta-Cyclodextrins; Chemistry, Pharmaceutical; Dosage Forms; Drug Stability; Humans; Hungary; Multiple Myeloma; Oligopeptides; Piperazines; Pyrimidines; Quinolones; Quinuclidines; Solubility; Thiazoles; Triazoles; Voriconazole | 2013 |